arrow
Back
V

Vallerie V. McLaughlin

university of michigan

78H-index
916Paper Count
3.4WCitation Count
Published Papers 163
Publication Date
Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): a randomised, double-blind, placebo-controlled phase 3 study
err2026-07-28
err0
errOAAI
errVallerie V McLaughlin; Derek Solum; Daniel Lachant; Ali Ataya; Joan A Barberà; Gisela Bohns Meyer; Sung-A Chang; Richard Channick; Colin Church; John Feenstra; Sean Gaine; George Giannakoulas; Carlos Jerjes-Sanchez; Dinesh Khanna; Nick H Kim; Ronald Oudiz; Ioana R Preston; Namita Sood; Fernando Torres; Jean-Luc Vachiery
errShare
errSave
Sotatercept Safety and Efficacy in Intermediate–Low Risk Pulmonary Arterial Hypertension: A Pooled Analysis of PULSAR and STELLAR
errChest
IF8.6
err2026-05-27
err0
PREAI
errMardi Gomberg-Maitland; H. Ardeschir Ghofrani; J. Simon R. Gibbs; Marius M. Hoeper; Marc Humbert; Vallerie V. McLaughlin; Ioana R. Preston; Rogerio Souza; Aaron B. Waxman; Barry Miller; Jianxin Lin; Yaru Shi; Loïc Perchenet; James Strait; Alexandra G. Cornell; David B. Badesch
errShare
errSave
From Clinical Success to Physiologic Understanding
errJACC
IF0
err2026-04-22
err0
PREAI
errThomas M. Cascino; Marat Fudim; Vallerie V. McLaughlin
errShare
errSave
Characteristics, Treatment Patterns and Outcomes of Patients with Pulmonary Arterial Hypertension by Race and Ethnicity Using Real-World Data from the Combined OPUS/OrPHeUS Studies
err2025-11-19
err0
errOAAI
errLana D. Melendres-Groves; Richard N. Channick; Kelly M. Chin; Vallerie V. McLaughlin; Gwen MacDonald; Nicolas Martin; Rose Ong; Marinella Sandros; Nick H. Kim
errShare
errSave
Evaluating oral selexipag in PAH: Insights on survival, safety and dosing patterns from the complete observation period of GRIPHON and its open-label extension
err2025-11-14
err0
PREAI
errVallerie V. McLaughlin; Luke Howard; Jean Elwing; Catarina C. Fernandes; Sean Gaine; Nazzareno Galiè; Ronald J. Oudiz; Mylène Stefani; Simone Stickel; Paul Strachan; Yuichi Tamura; Nick H. Kim
errShare
errSave
Clinical validation of a machine-learned, point-of-care system to IDENTIFY pulmonary hypertension
err2025-09-22
err1
PREAI
errMcLean, Dalton; Rommel, John; Steuter, John A.; Carroll, William S.; Rabbat, Mark; Rajagopal, Sudarshan; Srinivasan, Venkatraman; Kereiakes, Dean J.; Roberts, Michael C.; Raval, Abhijit; Nemati, Navid; Fathieh, Farhad; Burton, Timothy; Gillins, Horace R.; Shadforth, Ian; Ramchandani, Shyam; Bridges, Charles R.; V. McLaughlin, Vallerie
errShare
errSave
Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis
err2025-09-01
err2
PREAI
errMcLaughlin, Vallerie V.; Hoeper, Marius M.; Badesch, David B.; Ghofrani, H. Ardeschir; Gibbs, J. Simon R.; Gomberg-Maitland, Mardi; Preston, Ioana R.; Souza, Rogerio; Waxman, Aaron B.; Kopec, Grzegorz; Meyer, Gisela; Olsson, Karen M.; Fu, Wei; Shi, Yaru; Miller, Barry; Kim, Samuel S.; Mackenzie, Harald S.; Brambatti, Michela; Patel, Mahesh J.; Koglin, Joerg; Cornell, Alexandra G.; Humbert, Marc
errShare
errSave
Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension Study
err2025-08-11
err0
errOAAI
errOlivier Sitbon; Sandeep Sahay; Pilar Escribano Subías; Ronald L. Zolty; John F. Kingrey; John J. Ryan; Irina Sobol; Namita Sood; Raymond L. Benza; Richard N. Channick; Kelly M. Chin; Robert P. Frantz; Hossein-Ardeschir Ghofrani; Anna R. Hemnes; Vallerie V. McLaughlin; Jean-Luc Vachiéry; Roham T. Zamanian; Anna ter Veer; Robert F. Roscigno; David Mottola; Ed Parsley; Richard Aranda; Lawrence S. Zisman; Luke S. Howard
errShare
errSave
Characteristics of Patients with Pulmonary Arterial Hypertension Receiving Selexipag in the SPHERE Registry by Race and Ethnicity
err2025-08-04
err0
errOAAI
errHarrison W. Farber; Murali M. Chakinala; Anna R. Hemnes; Kelly M. Chin; Kristin B. Highland; Vallerie V. McLaughlin; Lana D. Melendres-Groves; Michelle Cho; Gurinderpal Doad; Elham Fatehi; Michelle Han; Mohammad Rahman; Paul Strachan; Tobore Tobore; Nick H. Kim
errShare
errSave
errShare
errSave
Safety and efficacy of riociguat in patients with pulmonary arterial hypertension and cardiometabolic comorbidities: Data from interventional clinical trials
err2025-02-01
err1
PREAI
errRosenkranz, Stephan; Ghofrani, Hossein-Ardeschir; Hoeper, Marius M.; Langleben, David; Hegab, Sara; Rahner, Claudia; Richard, Jean-Francois; Mclaughlin, Vallerie V.
errShare
errSave
A new day has come: Sotatercept for the treatment of pulmonary arterial hypertension
err2025-01-01
err3
PREAI
errCascino, Thomas M.; Sahay, Sandeep; Moles, Victor M.; Mclaughlin, Vallerie V.
errShare
errSave
Changes in REVEAL Lite 2 risk status are associated with long-term outcomes in patients with pulmonary arterial hypertension: A post-hoc analysis of the GRIPHON study
err2024-12-01
err0
PREAI
errBenza, Raymond L.; Chin, Kelly M.; Gaine, Sean; Galie, Nazzareno; Hoeper, Marius M.; Lang, Irene M.; V. McLaughlin, Vallerie; Sitbon, Olivier; Doad, Gurinderpal; Yen, Joseph; Tang, Xiaoqin; Tapson, Victor
errShare
errSave
Macitentan in Pulmonary Arterial Hypertension Due to Congenital Heart Disease (CHD-PAH): Real-World Evidence from the OPUS/OrPHeUS Studies
err2024-11-25
err0
errOAAI
errChin, Kelly M.; Channick, Richard; Kim, Nick H.; Ong, Rose; Turricchia, Stefano; Martin, Nicolas; Mitchell, Lada; Mclaughlin, Vallerie V.
errShare
errSave
Safety and efficacy of rodatristat ethyl for the treatment of pulmonary arterial hypertension (ELEVATE-2): a dose-ranging, randomised, multicentre, phase 2b trial
err2024-11-01
err1
PREAI
errSitbon, Olivier; Skride, Andris; Feldman, Jeremy; Sahay, Sandeep; Shlobin, Oksana A.; Mclaughlin, Vallerie; Ghofrani, Hossein-Ardeschir; Langleben, David; Parsley, Ed; D'Souza, Gwyn; Marmon, Tonya; Kamau-Kelley, Watiri; Jones, Renee; Grewal, Ravi; Wring, Steve; Palacios, Michelle; Naik, Himanshu; Denning, Jill; Lazarus, Howard M.; Humbert, Marc
errShare
errSave
Sustained effect of seralutinib on circulating biomarkers: Lessons from the TORREY phase 2 open-label extension study
err2024-10-30
err0
PREAI
errOsterhout, Robin; Hemnes, Anna R.; Sitbon, Olivier; Ghofrani, Hossein-Ardeschir; Benza, Raymond L.; Channick, Richard N.; Chin, Kelly M.; Frantz, Robert P.; Howard, Luke S.; V. Mclaughlin, Vallerie; Vachiery, Jean-Luc; Roscigno, Robert F.; Zisman, Lawrence S.; Aranda, Richard; Bruey, Jean-Marie; Zamanian, Roham T.
errShare
errSave
Real-world experience with selexipag in patients with pulmonary arterial hypertension in North America and Europe
err2024-10-30
err0
PREAI
errKim, Nick; Chakinala, Murali; Chin, Kelly; Didden, Eva-Maria; Doad, Gurinderpal; Farber, Harrison; Gaine, Sean; Hemnes, Anna; Highland, Kristin; Lange, Tobias; Mclaughlin, Vallerie; Muller, Audrey; Rahman, Mohammad; Remenova, Tatiana; Soderberg, Stefan; Venkatesh, Apoorva; Subias, Pilar Escribano
errShare
errSave
Sustained benefit with seralutinib treatment: Lessons from the open-label extension (OLE) of the TORREY study
err2024-10-30
err0
PREAI
errMcLaughlin, Vallerie V.; Hoffman, Sidra; Sahay, Sandeep; Subias, Pilar Escribano; Zolty, Ronald L.; Kingrey, John F.; Penn, Brittany; Sobol, Irina; Sood, Namita; Benza, Raymond L.; Channick, Richard N.; Chin, Kelly M.; Frantz, Robert P.; Ghofrani, Hossein-Ardeschir; Hemnes, Anna R.; Howard, Luke S.; Vachiery, Jean-Luc; Zamanian, Roham T.; Cravets, Matt; Osterhout, Robin; Roscigno, Robert F.; Parsley, Ed; Aranda, Richard; Zisman, Lawrence S.; Sitbon, Olivier
errShare
errSave